July 28, 2021 -- Bio-Techne and Progen have launched the Simple Plex adeno-associated virus 2 (AAV2) viral titer assay for AAV2 total capsid quantification.
The assay combines the scalability and automation of the Ella platform with AAV reagents from Progen, according to Bio-Techne. It features hands-free automation and utilizes Progen's recombinant AAV2 antibody (A20R) to quantify assembled AAV2 capsids. Also, the assay is designed to minimize variability and ensure optimum and consistent quantitation throughout the viral purification process, the company noted.